ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

PLX Company Profile and Key Details

AMEX : PLX

Protalix BioTherapeutics, Inc.

$2.51

0.025+1.01%

Open: 12:06 PM

62.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

PLX Stock Price Chart

Stock Price Today

Protalix BioTherapeutics, Inc. (PLX) stock surged +1.01%, trading at $2.51 on AMEX, up from the previous close of $2.48. The stock opened at $2.50, fluctuating between $2.46 and $2.57 in the recent session.

Stock Snapshot

2.48

Prev. Close

2.5

Open

195.47M

Market Cap

78.03M

Number of Shares

2.46

Day Low

2.565

Day High

62.62

P/E Ratio

92.48%

Free Float in %

0.04

EPS (TTM)

0.46

Book Value

-0.03

Cash Flow per Share

164.2K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 26, 2025	2.53	2.53	2.46	2.48	323.99K
Mar 25, 2025	2.60	2.61	2.52	2.53	506K
Mar 24, 2025	2.57	2.66	2.53	2.60	997.01K
Mar 21, 2025	2.35	2.49	2.30	2.49	670.08K
Mar 20, 2025	2.26	2.40	2.24	2.36	555.82K
Mar 19, 2025	2.33	2.44	2.25	2.25	711.5K
Mar 18, 2025	2.49	2.51	2.22	2.35	1.2M
Mar 17, 2025	2.37	2.65	2.37	2.45	1.97M
Mar 14, 2025	2.21	2.24	2.16	2.24	696.35K
Mar 13, 2025	2.26	2.27	2.13	2.17	594.16K
Mar 12, 2025	2.27	2.30	2.22	2.24	447.75K
Mar 11, 2025	2.34	2.36	2.21	2.26	558.2K
Mar 10, 2025	2.34	2.36	2.30	2.33	2.35M
Mar 07, 2025	2.35	2.37	2.32	2.34	468.25K
Mar 06, 2025	2.36	2.37	2.32	2.37	620.7K
Mar 05, 2025	2.33	2.37	2.32	2.37	454.41K
Mar 04, 2025	2.29	2.36	2.28	2.32	591.54K
Mar 03, 2025	2.35	2.41	2.30	2.31	967.65K
Feb 28, 2025	2.28	2.37	2.20	2.33	650.04K
Feb 27, 2025	2.39	2.39	2.27	2.33	368.5K

Contact Details

Hackensack, NJ 07601

United States

Website: https://www.protalix.comContact: 201 696 9345

About Company

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.

Frequently Asked Questions

What is the current Protalix BioTherapeutics, Inc. (PLX) stock price?

Protalix BioTherapeutics, Inc. (AMEX: PLX) stock price is $2.51 in the last trading session. During the trading session, PLX stock reached the peak price of $2.57 while $2.46 was the lowest point it dropped to. The percentage change in PLX stock occurred in the recent session was 1.01% while the dollar amount for the price change in PLX stock was $0.03.

PLX's industry and sector of operation?

The AMEX listed PLX is part of Biotechnology industry that operates in the broader Healthcare sector. Protalix BioTherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PLX?

Ms. Yael Fellous
Vice President of HR
Mr. Yaron Naos
Senior Vice President of Operations
Mr. Dror Bashan
Pres, Chief Executive Officer & Director
Mr. Eyal Rubin M.B.A.
Senior Vice President, Chief Financial Officer, Treasurer & Corporation Sec.

How PLX did perform over past 52-week?

PLX's closing price is 202.44% higher than its 52-week low of $0.82 where as its distance from 52-week high of $2.76 is -10.14%.

How many employees does PLX have?

Number of PLX employees currently stands at 208.

Link for PLX official website?

Official Website of PLX is: https://www.protalix.com

How do I contact PLX?

PLX could be contacted at phone 201 696 9345 and can also be accessed through its website. PLX operates from 2 University Plaza, Hackensack, NJ 07601, United States.

How many shares of PLX are traded daily?

PLX stock volume for the day was 164.2K shares. The average number of PLX shares traded daily for last 3 months was 708.85K.

What is the market cap of PLX currently?

The market value of PLX currently stands at $195.47M with its latest stock price at $2.51 and 78.03M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	208
Beta	0.72
Sales or Revenue	$65.49M
5Y Sales Change%	-0.583%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology